-
EPI-001 Workflow for AR N-Terminal Inhibition
2026-09-15
EPI-001 enables researchers to interrogate ligand-dependent, ligand-independent, and ARv7-associated signaling in prostate cancer and exploratory TNBC models. This practical workflow connects formulation, viability, migration, localization, and EMT readouts while highlighting controls that improve reproducibility.
-
Palbociclib in Patient-Derived Gastric Assembloids
2026-09-15
Palbociclib (PD0332991) is more than a CDK4/6 inhibitor for measuring cell-cycle arrest: in paired gastric organoid and assembloid workflows, it can help reveal how stromal context reshapes drug response. This guide translates recent assembloid findings into practical assay-design and interpretation strategies.
-
T-5224 for AP-1 Inflammation Research
2026-09-14
T-5224 is a selective C-Fos/AP-1 inhibitor for separating AP-1-dependent inflammatory transcription from broader stress signaling. This practical guide connects arthritis cell workflows with the Ca2+-linked neuroinflammatory mechanisms reported in trigeminal neuralgia, while clearly distinguishing validated evidence from assay-extension ideas.
-
A Click-Compatible BmTyr Platform in Primary T Cells
2026-09-14
This study introduces an engineered, copper-dependent BmTyr platform that uses an alkyne-phenol probe and azide-bearing tags for biotin-free proximity labeling in primary T cells. The workflow supports fluorescence imaging, affinity enrichment, mass spectrometry, and sensitive low-input validation, while revealing a previously unappreciated chromatin-associated localization of NKAP.
-
Cisplatin (CDDP) Workflows for Cancer Research
2026-09-13
Cisplatin (CDDP) provides a practical benchmark for linking DNA crosslinking to apoptosis, oxidative stress, and treatment resistance. This guide combines cell-based assay design, xenograft readouts, and ferroptosis-informed troubleshooting to improve experimental interpretation.
-
Phosbind Biotin LC Western Blot Guide
2026-09-12
Phosbind Biotin LC is a phosphate-binding reagent for sequence-independent detection of phosphorylated proteins on PVDF membranes. It is suited to Western Blot phosphorylated protein detection with streptavidin-HRP and chemiluminescence, but it should not be used in aqueous-only workflows or with working solutions intended for long-term storage.
-
ARCA EGFP mRNA (5-moUTP): Assay Design Guide
2026-09-12
ARCA EGFP mRNA (5-moUTP) is a polyadenylated mRNA reporter for measuring delivery and protein expression in mammalian cells. This guide explains how cap orientation, nucleotide modification, assay context, and delivery variables should shape interpretation of fluorescence data.
-
LY2886721: Practical BACE Inhibitor Workflows
2026-09-11
LY2886721 supports controlled BACE1 enzyme inhibition across amyloid-processing assays, neuronal synaptic studies, and oral transgenic-mouse workflows. Its nanomolar activity and dose-dependent biomarker effects make it useful for distinguishing moderate amyloid beta reduction from excessive pathway suppression.
-
CARD8 Inflammasome Activation in Resting Lymphocytes
2026-09-11
Johnson and colleagues show that DPP8/9 inhibitors can trigger CARD8-dependent pyroptosis in resting human and rodent lymphocytes, particularly CD4+ and CD8+ T cells. The study expands inflammasome biology beyond myeloid cells and demonstrates that lymphocyte activation state, species, and donor background strongly influence susceptibility.
-
AEBSF.HCl in Protease and Necroptosis Research
2026-09-10
AEBSF.HCl provides irreversible, broad-spectrum serine protease control for APP processing, amyloid-beta studies, cell lysis, and protease-dependent death assays. Its most valuable use in necroptosis research is as a pathway-dissection reagent that complements, rather than replaces, direct lysosomal cathepsin analysis.
-
TCEP Hydrochloride: Disulfide Reduction Guide
2026-09-10
Tris(2-carboxyethyl) phosphine hydrochloride, also called TCEP hydrochloride, is a thiol-free, water-soluble reagent for reducing protein disulfide bonds. Its defined physical properties and broad biochemical utility support protein digestion enhancement, structural analysis, and selected redox workflows, but direct validation is required for each assay.
-
BFH772 (VEGFR2 inhibitor): Practical Workflow
2026-09-09
BFH772 is a selective small-molecule VEGFR2 inhibitor for controlled studies of VEGFR2-driven signaling and angiogenesis. Its organic-solvent solubility, water insolubility, and selectivity profile make it unsuitable for unvalidated aqueous formulations or experiments requiring broad-spectrum kinase inhibition.
-
Cardiogreen: From Vascular Dye to Immune PTT
2026-09-09
Cardiogreen (Indocyanine green) is more than a vascular imaging dye: its optical behavior supports a framework for connecting photothermal treatment with immune assay design. This article explains how recent oral cancer research reshapes experimental decisions around calreticulin exposure, macrophage phagocytosis, and extracellular-matrix access.
-
AR/ARv7 Targeting in TNBC: Study Insights
2026-09-08
This 2025 study connects AR and ARv7 expression with adverse clinical features in triple-negative breast cancer and examines how enzalutamide and EPI-001 alter metastatic and epithelial–mesenchymal transition markers in MDA-MB-231 cells. Its main contribution is the integration of patient biomarker data, TCGA analysis, and pharmacological experiments, while also identifying the ROCK/NF-κB/c-Myc axis as a mechanism for further investigation.
-
Vancomycin: Mechanism and MRSA Research Guide
2026-09-08
Vancomycin is a glycopeptide antibiotic and bacterial cell wall synthesis inhibitor that binds D-Ala-D-Ala termini in peptidoglycan precursors. Its defined target, MRSA relevance, and documented formulation properties support controlled bacterial resistance and Clostridium difficile infection research.